antigen
Enable an agent to identify an antigen, assess evidence of immune recognition and preparation quality, and determine its suitability for a specified research, diagnostic, or immunological use.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
recalled by Codex without web access - no source was read
Researched by: Codex
Purpose and description
Enable an agent to identify an antigen, assess evidence of immune recognition and preparation quality, and determine its suitability for a specified research, diagnostic, or immunological use.
An antigen is a molecular structure specifically recognized by an antibody or B-cell receptor, or by a T-cell receptor in an appropriate molecular presentation context, whether or not it induces an immune response.
It can be Resolve an antigen candidate to a defined molecular entity or explicitly bounded material.; Map recognition evidence to specific epitopes, partners, and presentation contexts.; Compare variants or preparations for demonstrated changes in recognition.; Select a preparation for a specified assay using measured quality and recognition criteria.; Identify missing controls or experiments needed to test specificity or immunogenicity.; Flag storage, handling, or processing changes that require recognition to be reassessed..
Distinguishing features
An antigen assignment requires a specified immune-recognition relationship or an explicitly unverified candidate status; biological origin alone does not establish antigenicity.
Recognition and immune-response induction are separate tests: evidence of binding alone does not establish that the material is an immunogen.
An epitope is a recognized feature of an antigen; identifying one epitope does not necessarily identify or characterize the whole antigen.
For presentation-dependent recognition, the tested entity must distinguish the source material, presented component, and presenting molecule.
A cell, pathogen, or formulated product carrying an antigen is not interchangeable with the particular antigenic determinant or preparation under investigation.
Scope
+ Molecular identity, biological origin, and material boundaries of the antigen
+ Epitopes and their accessibility in specified molecular conformations
+ Recognition by specified antibodies, B-cell receptors, or T-cell receptors
+ Processing and presentation requirements where recognition depends on them
+ Preparation quality, stability, and suitability for a stated use
+ Evidence distinguishing antigen recognition from immune-response induction
- Complete models of the organism, cell, or tissue carrying the antigen
- Antibody or receptor engineering beyond its relationship to antigen recognition
- Complete vaccine, diagnostic kit, or therapeutic product formulations
- Host immune-system state, disease diagnosis, and treatment decisions
- Manufacturing facilities and production processes beyond preparation provenance
Characteristics
- Antigen entity and molecular identity
- Defined molecule, molecular complex, heterogeneous material, or unresolved candidate; sequence, structure, and identifiers where applicable Prevents treating antigen as a single chemical substance or assigning one chemical identifier to an unresolved mixture.
- Biological source and variant
- Source organism, strain, tissue, cell type, allele, or synthetic design Connects recognition claims to the source and variation actually represented.
- Epitope identity and dependence
- Mapped or unresolved; sequence, structural region, chemical determinant, and conformation or modification dependence Identifies what is recognized and what changes could remove or alter recognition.
- Recognition partner
- Specified antibody, B-cell receptor, T-cell receptor, or characterized polyclonal population Makes antigenicity an evidenced relationship rather than an unconditional material label.
- Presentation context
- Direct recognition, specified presenting molecule and presented component, other demonstrated context, or unresolved Prevents transferring recognition claims between incompatible presentation settings.
- Binding affinity
- Dissociation constant in mol/L, with partner, method, temperature, and binding model; unresolved when unavailable Supports comparison when the experiment measures affinity and its assumptions are appropriate.
- Immune-response induction evidence
- Not tested, response detected, response not detected, or inconclusive; qualified by host, endpoint, dose, route, and formulation Separates antigen recognition from context-dependent immunogenicity.
- Preparation composition and concentration
- Purity or component fraction with method; concentration in mg/mL or mol/L where meaningful Determines what material was tested and whether preparations can be compared.
- Recognition-relevant preparation state
- Measured folding, aggregation, degradation, modification, and epitope-accessibility state A nominally identical antigen can behave differently after processing or storage.
- Use qualification
- Qualified, unqualified, or unresolved for a named application and acceptance criteria Keeps suitability specific to the intended assay or intervention.
Also called
Where this came from
wikidata · CC0 1.0
Also registered as vr.tr.antigen
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 18 findings · 28 questions.
Antigen identity Define the physical entity bearing the antigen role and connect it to its source.
Antigen is a recognition role spanning different materials, so a name alone cannot establish molecular identity.
Molecular boundary
Separate the antigen entity from its epitopes, carriers, and surrounding material.
Recognized entity
Record whether the entry concerns a defined molecule, complex, or bounded heterogeneous preparation.
- What molecular entity or material does the antigen name denote, and which identifiers or structural descriptions support that identity? definition
- Does the name refer to a whole antigen, an epitope, a carrier conjugate, or a preparation containing multiple antigens? boundary
Source and variation
Connect identity to biological origin or synthetic design and distinguish relevant variants.
Source-linked variant
Record the source, sequence or chemical variant, and modifications represented by the material.
- Which organism, strain, tissue, allele, or synthetic design produced the antigen being described? provenance
- Which sequence changes, chemical modifications, or conjugations distinguish this antigen from related variants? definition
Epitopes and recognition Describe the determinants recognized and the experimental relationships supporting antigenicity.
Recognition must be tied to a determinant and partner rather than inferred from the antigen label.
Epitope structure
Locate recognized determinants and identify dependencies on molecular state.
Determinant and accessibility
Record epitope mapping and evidence that the determinant is accessible in the relevant material.
- Which residues, chemical groups, or structural regions define the epitope, and how was that assignment established? measurement
- Does recognition depend on folding, modification, cleavage, or exposure that differs between the tested preparation and its native context? boundary
Binding specificity
Associate recognition measurements with partners, controls, and assay conditions.
Partner-qualified recognition
Record binding or recognition evidence without conflating assay signal, affinity, and avidity.
- Which antibody or receptor recognizes the antigen, by what assay, and with which negative and competition controls? measurement
- What related or unrelated materials were tested for cross-reactivity, and does the reported measurement represent affinity, avidity, or assay response? boundary
Presentation and immune response Specify recognition context and separately assess evidence of immune-response induction.
Recognition may depend on processing and presentation, while immunogenicity requires additional contextual evidence.
Processing and presentation
Distinguish source antigen from the component and molecular context encountered by a receptor.
Presented recognition unit
Record direct or presentation-dependent recognition and the evidence connecting source material to the recognized unit.
- Is recognition direct or presentation-dependent, and which presented component and presenting molecule are required? definition
- What demonstrates that the source antigen generates the recognized component in the relevant cells, rather than only after experimental loading? measurement
Immunogenicity context
Qualify induced responses by host, exposure, formulation, and endpoint.
Recognition versus induction
Keep evidence of an induced immune response distinct from evidence of recognition by existing immune reagents.
- Has response induction been tested, and in which host, dose, route, formulation, and observation period? measurement
- Which controls distinguish the response to this antigen from responses to its carrier, adjuvant, or contaminants? boundary
Preparation integrity Characterize the physical preparation whose antigenic behavior is being assessed.
Composition, processing, and deterioration can change recognition or confound immune-response measurements.
Composition and confounders
Measure antigen content and identify constituents that could affect interpretation.
Tested material composition
Record preparation identity, concentration, purity, and assay-relevant impurities.
- How were antigen identity, concentration, and purity measured for the tested lot? measurement
- Which carrier proteins, expression tags, residual host materials, or immune-active contaminants could contribute to the observed result? boundary
Stability and accessibility
Assess whether handling preserves the antigen features required for recognition.
Retained antigenic state
Link storage and processing history to measured structural integrity and recognition.
- What changes in aggregation, degradation, folding, or recognition occur under the proposed storage and handling conditions? measurement
- Which acceptance criteria determine whether a stored, thawed, fixed, or immobilized preparation remains suitable for its intended recognition assay? action
Application and evidence limits Translate antigen evidence into bounded use decisions and explicit unresolved claims.
Suitability depends on the application, and results from one preparation or recognition context may not transfer.
Application qualification
Connect a proposed use to recognition performance and preparation-specific requirements.
Fit for intended use
Define the evidence needed to use the antigen in a particular experimental or product context.
- For the proposed assay or immunological use, which recognition, specificity, and preparation-quality criteria must be met? action
- Which handling restrictions or regulatory requirements apply to this actual preparation and use, including its source material and formulation? action
Claim transfer and gaps
Bound the transfer of results across variants, lots, hosts, and presentation settings.
Evidence-bounded conclusions
Associate each conclusion with the material and context tested, and identify further validation needs.
- Which records connect each recognition or immune-response claim to its tested antigen variant, preparation lot, and experimental context? provenance
- What additional evidence is required before transferring the claim to another variant, lot, host population, or presentation context? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- Antigen denotes an immunological role across diverse molecular structures, not one chemical substance; no universal CAS number, purity, melting point or GHS classification applies.
- The listed kinds overlap and represent different classification axes rather than mutually exclusive categories.
- For a concrete entry, establish the molecular identity, epitope, preparation and recognition context; most conventional T cells recognize peptide-MHC complexes, but other presentation systems exist.
- Which of these check these first hold for the sense of antigen this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Self antigens (autoantigens)
- Alloantigens differing among individuals of the same species
- Microbial antigens
- Tumour-associated antigens
- T-dependent antigens
- T-independent antigens
- Which of these kinds and varieties hold for the sense of antigen this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- UniProt accession - Accession identifying a particular protein sequence record - Applicable to protein antigens; it does not by itself specify the recognized epitope or antigen preparation.
- Immune Epitope Database (IEDB) epitope identifier - Numeric epitope record identifier - Identifies a recorded epitope rather than necessarily the entire antigen.
- Which of these identifiers and schemes hold for the sense of antigen this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Vaccine components intended to elicit antigen-specific immunity
- Targets detected by diagnostic immunoassays
- Reagents used to detect antigen-specific antibodies or cellular responses
- Blood-group and tissue-compatibility testing
- Targets for therapeutic antibodies and cellular immunotherapies
- Which of these real-world use hold for the sense of antigen this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Antigen mass concentration - Preparation- and assay-dependent; no class-wide range - ng/mL or µg/mL
- Antibody-antigen equilibrium dissociation constant - Specific to the binding pair and experimental conditions - mol/L
- Which of these typical measurements hold for the sense of antigen this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Cross-reactive recognition can produce misleading diagnostic results or unintended biological effects.
- Denaturation, degradation or chemical modification can destroy or alter epitopes.
- Antigenic variation can reduce recognition by existing antibodies or T cells.
- Some antigens participate in allergic or autoimmune responses; antigenicity alone does not establish a hazard.
- Contaminants such as endotoxin can confound experiments or make an antigen preparation unsafe.
- Which of these failure modes and hazards hold for the sense of antigen this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Regulatory requirements depend on whether an antigen preparation is used as a vaccine component, diagnostic reagent or research material, and on the jurisdiction.
- Which of these regional variation hold for the sense of antigen this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- immunogen - An immunogen induces an immune response under specified conditions; an antigen need only be specifically recognized.
- epitope - An epitope is the particular molecular feature recognized; an antigen can contain multiple epitopes.
- hapten - A hapten can be specifically bound but generally requires association with a carrier to induce an antibody response.
- allergen - An allergen is an antigen that elicits an allergic immune response in a susceptible individual.
- antibody - An antibody is an immunoglobulin recognition molecule; the antigen is its binding target, although antibodies can themselves act as antigens.
- adjuvant - An adjuvant enhances responses to an antigen rather than defining the target of antigen-specific recognition.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of antigen this model covers, and on what evidence? provenance
What the second pass must settle
- Which authoritative definition should anchor the registry's antigen scope, particularly for heterogeneous materials and nonclassical presentation contexts?
- Does an existing Vercy model already own antigen, epitope, or immunogen, and which relationships would preserve one source of truth?
- What minimum recognition evidence should distinguish a candidate antigen from a demonstrated antigen in the catalogue?
- Which criteria should determine whether molecular variants and carrier conjugates are separate antigen instances or states of the same instance?
- Which application-specific standards should govern preparation qualification and the transfer of recognition claims between contexts?